Analysis of adverse events with ruxolitinib using real-world datasets and drug-interaction networks

Analysis of adverse events with ruxolitinib using real-world datasets and drug-interaction networks

Objectives: Ruxolitinib is used to treat myelofibrosis, polycythemia vera, and steroid-refractory graft-versus-host disease following allogeneic stem cell transplantation. This study aimed to determine the association between ruxolitinib and adverse events by evaluating case reports published betwee...

Full description

Saved in:
Bibliographic Details
Main Authors: Hideyuki Tanaka, Mika Maezawa, Mizuki Tanaka, Ryogo Umetsu, Sakiko Hirofuji, Koumi Miyasaka, Satoshi Nakao, Yuka Nokura, Moe Yamashita, Nanaka Ichihara, Kana Sugishita, Tomofumi Yamazaki, Kohei Shiota, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamura
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/20503121251348420
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items